simendan has been researched along with Pregnancy in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Jothin, A; Raj, JP; Thiruvenkatarajan, V | 1 |
| Avram, R; Desplantie, O; Ducharme, A; Jolicoeur, EM; Marquis-Gravel, G; Tremblay-Gravel, M | 1 |
| Alsina, E; Brogly, N; Gilsanz, F; Guasch, E; López, T; Puertas, L | 1 |
| Akgün, T; Biteker, M; Duran, NE; Gökdeniz, T; Gündüz, S; Kahveci, G; Kaya, H; Õzkan, M; Tanboğa, HÎ; Yildiz, M | 1 |
| Benlolo, S; Katchatouryan, V; Lefoll, C; Mebazaa, A; Payen, D | 1 |
| Nacitarhan, C; Seyrek, M; Yildiz, O | 1 |
| Krumnikl, JJ; Metzler, H; Prenner, G; Toller, WG | 1 |
| Benezet-Mazuecos, J; de la Hera, J | 1 |
1 review(s) available for simendan and Pregnancy
| Article | Year |
|---|---|
The Medical Treatment of New-Onset Peripartum Cardiomyopathy: A Systematic Review of Prospective Studies.
Topics: Bromocriptine; Cardiomyopathies; Echocardiography; Female; Humans; Hydrazones; Pentoxifylline; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Puerperal Disorders; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Survival Rate; Ventricular Dysfunction, Left | 2015 |
1 trial(s) available for simendan and Pregnancy
| Article | Year |
|---|---|
Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial.
Topics: Adult; Cardiomyopathies; Cardiovascular Agents; Drug Therapy, Combination; Echocardiography; Female; Heart Ventricles; Humans; Hydrazones; Peripartum Period; Predictive Value of Tests; Pregnancy; Pregnancy Complications, Cardiovascular; Pyridazines; Simendan; Treatment Outcome; Vasodilator Agents; Ventricular Function, Left; Young Adult | 2011 |
6 other study(ies) available for simendan and Pregnancy
| Article | Year |
|---|---|
A simple procedure in a complex patient: perioperative takotsubo cardiomyopathy.
Topics: Abortion, Induced; Adult; Cardiotonic Agents; Catecholamines; Echocardiography; Electrocardiography; Female; Heart Arrest; Humans; Infusions, Intravenous; Intraoperative Complications; Pregnancy; Simendan; Stress, Psychological; Takotsubo Cardiomyopathy | 2020 |
[Acute early postpartum cardiac failure associated with dilated cardiomyopathy: successful treatment with intra-aortic balloon counter-pulsation and levosimendan].
Topics: Adult; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Cesarean Section; Echocardiography; Female; Heart Failure; Humans; Hydrazones; Intra-Aortic Balloon Pumping; Postpartum Period; Pregnancy; Pyridazines; Simendan; Stroke Volume; Ventricular Function, Left | 2010 |
Successful use of levosimendan in a patient with peripartum cardiomyopathy.
Topics: Adult; Anesthesia, Obstetrical; Apnea; Cardiomyopathies; Female; Hemodynamics; Humans; Hydrazones; Pregnancy; Pregnancy Complications, Cardiovascular; Pyridazines; Simendan; Vasodilator Agents | 2004 |
Potassium channels in the vasodilating action of levosimendan on the human umbilical artery.
Topics: Cardiotonic Agents; Female; Humans; Hydrazones; Muscle Contraction; Muscle, Smooth; Placental Circulation; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Potassium Channels, Voltage-Gated; Pregnancy; Pyridazines; Simendan; Umbilical Arteries; Vasodilation | 2006 |
Beneficial outcome after prostaglandin-induced post-partum cardiac arrest using levosimendan and extracorporeal membrane oxygenation.
Topics: Adult; Cardiotonic Agents; Catecholamines; Cesarean Section; Drug Resistance; Extracorporeal Membrane Oxygenation; Female; Heart Arrest; Hemodynamics; Humans; Hydrazones; Lung Diseases; Postpartum Hemorrhage; Pregnancy; Prostaglandins; Pyridazines; Simendan; Treatment Outcome; Uterine Diseases | 2006 |
Peripartum cardiomyopathy: a new successful setting for levosimendan.
Topics: Adult; Cardiotonic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Postpartum Period; Pregnancy; Pyridazines; Risk Assessment; Severity of Illness Index; Simendan; Treatment Outcome; Ventricular Dysfunction, Left | 2008 |